rash accompanied by an itchy, tingling sensation; flushing; rash accompanied by an itchy, tingling sensation; rash along the middle of her chest that radiated up her neck and some on her face; scattered throughout her body; body aches; slight headache; Extreme fatigue; Joint pain; lethargic with feeling of less energy throughout the day; felt awful for a few days; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic with feeling of less energy throughout the day), VACCINATION COMPLICATION (felt awful for a few days), PARAESTHESIA (rash accompanied by an itchy, tingling sensation), FLUSHING (flushing) and PRURITUS (rash accompanied by an itchy, tingling sensation) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Allergic to aspirin), Optic disc drusen (Drusen optic nerve both eyes), Sulfonamide allergy, Drug allergy (Allergic to tramadol), Migraine, Menopause, Drug allergy (Allergic to eye drops- itching eyes) and Drug allergy (Allergic to "pain medications"- itching). Concomitant products included LORATADINE for Allergy, ASCORBIC ACID, CITRUS AURANTIUM, HYDROXYCITRIC ACID, LECITHIN, MALUS SPP. (APPLE CIDER VINEGAR WITH GRAPEFRUIT EXTRACT) for Digestion impaired, BIMATOPROST (LUMIGAN) for Increased intraocular pressure, ESTROVEN for Menopause, NORTRIPTYLINE HCL for Migraine, DIPHENHYDRAMINE for Sleeplessness, FISH OIL, LINUM USITATISSIMUM SEED OIL (FLAX SEED OIL) and MULTIVITAMIN & MINERAL for Supplementation therapy.    On 12-Apr-2021 at 9:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced LETHARGY (lethargic with feeling of less energy throughout the day), PARAESTHESIA (rash accompanied by an itchy, tingling sensation), FLUSHING (flushing), PRURITUS (rash accompanied by an itchy, tingling sensation), RASH (rash along the middle of her chest that radiated up her neck and some on her face; scattered throughout her body), MYALGIA (body aches), HEADACHE (slight headache), FATIGUE (Extreme fatigue) and ARTHRALGIA (Joint pain). On an unknown date, the patient experienced VACCINATION COMPLICATION (felt awful for a few days). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at a dose of 1 dosage form. On 12-Apr-2021, HEADACHE (slight headache) had resolved. On 19-Apr-2021, PARAESTHESIA (rash accompanied by an itchy, tingling sensation), FLUSHING (flushing), PRURITUS (rash accompanied by an itchy, tingling sensation), RASH (rash along the middle of her chest that radiated up her neck and some on her face; scattered throughout her body) and ARTHRALGIA (Joint pain) had resolved, FATIGUE (Extreme fatigue) had not resolved. At the time of the report, LETHARGY (lethargic with feeling of less energy throughout the day) and MYALGIA (body aches) had not resolved and VACCINATION COMPLICATION (felt awful for a few days) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       Patient stated that her physician recommended she not receive the second dose.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Patient demographics updated, medical history added,  concomitant medications added. On 20-Jul-2021: allergies updated, added the event flushing